AUG 29, 2020 7:34 AM PDT

MDMA and LSD Combo to Enter Clinical Trials

WRITTEN BY: Annie Lennon

Scientists from the pharmaceutical company, MindMed, have announced the beginning of Phase 1 clinical trials to test Schedule 1 drugs MDMA and LSD. The trial will commence in Basel, Switzerland, later this year, and is the first robust clinical trial to investigate how the two drugs work together. 

For the study, the researchers will recruit 24 healthy subjects to undergo four different experimental sessions. In one session, participants will be dosed with 100 micrograms of LSD mixed alongside an MDMA placebo. In another, they will receive an LSD placebo and 100 milligrams of MDMA. In the last two, they will receive placebos both for LSD and MDMA, and 100 micrograms of LSD accompanied by 100 milligrams of MDMA. 

Alongside each combination's subjective effects, the researchers will also assess measures, including heart rate, blood pressure, and body temperature. Until now, they suspect that the two drugs may work synergistically to deliver better therapeutic outcomes than when taken alone. 

Although MDMA and LSD have both been known for some time now for their therapeutic potential- with MDMA, in particular, receiving attention from ongoing trials of the drug and psychotherapy, there is currently very little research showing how the drugs may work in tandem. 

While LSD is known to induce feelings of ego dissolution that can result in introversion and anxiety, MDMA is known to enhance feelings of comfort and wellbeing. As such, the researchers suspect that MDMA may be able to 'take the edge' off of LSD. 

"The potential of MDMA-LSD is to create a psychological state that may have the benefits of both substances and have longer-lasting effects than standalone psilocybin or LSD," says Dr. Matthias Liechti, a professor at the University of Basel and lead researcher of the study.

"Inducing an overall primarily positive acute response during psychedelic-assisted therapy is critical because several studies showed that a more positive acute experience is linked to a greater therapeutic long-term effect in patients."

 

Sources: VicePR Newswire

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
OCT 29, 2020
Drug Discovery & Development
Scientists Create Antibiotic from Komodo Dragon Blood
OCT 29, 2020
Scientists Create Antibiotic from Komodo Dragon Blood
Researchers from George Mason University in Washington DC have created a synthetic molecule from Komodo Dragon blood tha ...
NOV 25, 2020
Drug Discovery & Development
Improving Drug Dissolution
NOV 25, 2020
Improving Drug Dissolution
When you take your medicine, it travels through the bloodstream and releases its effects. When the drug dissolves too fa ...
DEC 15, 2020
Drug Discovery & Development
Drug Reverses Age-Related Mental Decline
DEC 15, 2020
Drug Reverses Age-Related Mental Decline
An experimental drug, called ISRIB, has shown to reverse age-related mental decline in mice with just a few doses " ...
DEC 30, 2020
Drug Discovery & Development
Llama Antibody Prevents Infection by COVID-19
DEC 30, 2020
Llama Antibody Prevents Infection by COVID-19
There's more to llamas than being livestock and hilarious companion animals. They also harbor an immune system capab ...
JAN 05, 2021
Neuroscience
Synthetic Psychedelic Treats Depression Without Hallucinations
JAN 05, 2021
Synthetic Psychedelic Treats Depression Without Hallucinations
Psychedelics are receiving an increasing amount of attention- both in research and in the media- for their potential to ...
JAN 13, 2021
Drug Discovery & Development
Could Rotten Egg Gas Reverse Alzheimer's?
JAN 13, 2021
Could Rotten Egg Gas Reverse Alzheimer's?
Researchers from Johns Hopkins University have found that hydrogen sulfide, a gas that smells like rotten eggs, may prot ...
Loading Comments...